CRVS
Price
$4.17
Change
-$0.12 (-2.80%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
330.82M
5 days until earnings call
IPSC
Price
$0.54
Change
-$0.02 (-3.57%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
48.08M
One day until earnings call
Interact to see
Advertisement

CRVS vs IPSC

Header iconCRVS vs IPSC Comparison
Open Charts CRVS vs IPSCBanner chart's image
Corvus Pharmaceuticals
Price$4.17
Change-$0.12 (-2.80%)
Volume$7.46K
Capitalization330.82M
Century Therapeutics
Price$0.54
Change-$0.02 (-3.57%)
Volume$1.2K
Capitalization48.08M
CRVS vs IPSC Comparison Chart in %
Loading...
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVS vs. IPSC commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (CRVS: $4.10 vs. IPSC: $0.53)
Brand notoriety: CRVS and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 74% vs. IPSC: 66%
Market capitalization -- CRVS: $330.82M vs. IPSC: $48.08M
CRVS [@Biotechnology] is valued at $330.82M. IPSC’s [@Biotechnology] market capitalization is $48.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • CRVS’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, CRVS is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 4 bullish TA indicator(s).

  • CRVS’s TA Score: 3 bullish, 5 bearish.
  • IPSC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than CRVS.

Price Growth

CRVS (@Biotechnology) experienced а -12.95% price change this week, while IPSC (@Biotechnology) price change was -14.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.35%. For the same industry, the average monthly price growth was +19.02%, and the average quarterly price growth was +14.26%.

Reported Earning Dates

CRVS is expected to report earnings on Aug 12, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVS($331M) has a higher market cap than IPSC($48.1M). CRVS YTD gains are higher at: -22.056 vs. IPSC (-47.337). IPSC has higher annual earnings (EBITDA): -5.99M vs. CRVS (-31.13M). IPSC has more cash in the bank: 165M vs. CRVS (44.2M). CRVS has less debt than IPSC: CRVS (1.15M) vs IPSC (52.7M). IPSC has higher revenues than CRVS: IPSC (115M) vs CRVS (0).
CRVSIPSCCRVS / IPSC
Capitalization331M48.1M688%
EBITDA-31.13M-5.99M520%
Gain YTD-22.056-47.33747%
P/E RatioN/AN/A-
Revenue0115M-
Total Cash44.2M165M27%
Total Debt1.15M52.7M2%
FUNDAMENTALS RATINGS
CRVS: Fundamental Ratings
CRVS
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRVSIPSC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 6 days ago
82%
Momentum
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
86%
Bearish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTC34.290.25
+0.73%
LTC Properties
LIN459.41-0.85
-0.18%
Linde plc
JSPR2.88-0.02
-0.69%
Jasper Therapeutics
BYD83.65-1.25
-1.47%
Boyd Gaming Corp
ZUMZ13.27-0.44
-3.21%
Zumiez

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with SYRE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-2.80%
SYRE - CRVS
38%
Loosely correlated
-5.39%
TERN - CRVS
37%
Loosely correlated
-6.74%
VKTX - CRVS
36%
Loosely correlated
-6.32%
IPSC - CRVS
33%
Poorly correlated
-2.80%
DYN - CRVS
33%
Poorly correlated
+10.70%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-2.87%
CRSP - IPSC
56%
Loosely correlated
-0.30%
IMNM - IPSC
52%
Loosely correlated
+0.67%
ARWR - IPSC
51%
Loosely correlated
+0.82%
KYTX - IPSC
51%
Loosely correlated
-3.64%
NTLA - IPSC
50%
Loosely correlated
-1.29%
More